Schizophrenia Clinical Trials

Showing 181-200 of 1,172 trials

A Study for Schizophrenia Relapse Prediction

NCT03629951

The purpose of this study is to identify if there are self-reported/caregiver reported or objective measures that can predict near-term relapse (within 1 month or at another identified time point before meeting the criteria for relapse) or early symptomatic changes indicative of pre-relapse.

Schizophrenia

Janssen Research & Development, LLC333 participantsStarted Nov 2018

Ahmedabad, India • Ahmedabad, India • Hyderabad, India +7 more locations

COMPLETED

A Study to Analyze the Impact of Treatment With Paliperidone Palmitate on Clinical Outcomes and Hospital Resource Utilization in Adult Participants With Schizophrenia in Portugal

NCT03666715

The purpose of this study is to investigate the mean number of schizophrenia-related hospital admissions, in adult participants with schizophrenia, occurred during 12 months before and 12 months after initiation of Paliperidone Palmitate 1-month formulation treatment.

Schizophrenia

Janssen-Cilag Farmaceutica Ltda.55 participantsStarted Aug 2018

Porto, Portugal

A Study for Schizophrenia Relapse Prediction

A Study to Analyze the Impact of Treatment With Paliperidone Palmitate on Clinical Outcomes and Hospital Resource Utilization in Adult Participants With Schizophrenia in Portugal

Related Searches

Predictors of Functional Remission in Discharged Patients With Schizophrenia After Long-term Drug Discontinuation

A Study To Evaluate The Effect Of A Supratherapeutic Dose Of MK-8189 On The QTc Interval In Participants With Schizophrenia (MK-8189-019)

Mechanisms of Response to Therapeutic Intervention in Clinical High Risk (CHR) for Psychosis

Cognitive Remediation Therapy for Schizophrenia: Effects on EEG and Emotional Regulation

Safety and Efficacy of Brexpiprazole in the Treatment of Schizophrenia

An Open-Label Study to Evaluate the Efficacy and Tolerability of Xanomeline/Trospium In First Episode/Early Phase Schizophrenia Patients

Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

PET Imaging Study of α7 and α4β2-nAChR in Schizophrenia

Asylumseekers Experiencing Paranoid Delusions: A Virtual Reality Study

40 Hz Visual Stimulation as an Intervention in Schizophrenia

Efficacy and Mechanisms of TUS on Cognitive Deficits in Schizophrenia: Based on the Hippocampal-Prefrontal Circuit

The Effects of Non-invasive Brain Stimulation on Treatment Adherence in Schizophrenia

A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Co-Administration of Roluperidone and Olanzapine in Adult Subjects With Moderate to Severe Negative Symptoms of Schizophrenia

Shared Decision Making for Antipsychotic Medications

An Integrated Neurophysiological Approach Toward the Early Detection of Psychiatric Disorders

A Clinical Trial to Evaluate the Long-term Safety and Tolerability of SEP-363856 in Patients With Schizophrenia in Japan

Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis

Karolinska Schizophrenia Project